Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2017

Open Access 01.12.2017 | Case Report

Giant gastrointestinal stromal tumor with predominantly cystic changes: a case report and literature review

verfasst von: Liying Wang, Libin Liu, Zhaohui Liu, Yueli Tian, Zhe Lin

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2017

Abstract

Background

Gastrointestinal stromal tumors (GISTs) rarely present with predominantly cystic changes. Here, we report a case of giant GIST of the stomach with predominantly cystic changes in a 74-year-old female patient.

Case presentation

The tumor was 10 cm × 15 cm in size and positive for CD117, H-caldesmon, and DOG-1. Complete surgical resection was performed without regional lymphadenectomy. The patient recovered uneventfully and no recurrence occurred.

Conclusions

The case illustrates that GIST with cystic changes should be considered in the diagnoses of hepatic and pancreatic lesions. Furthermore, immunohistochemistry with CD117, DOG1, and other molecular markers is critical for diagnosis of GIST of the stomach and facilitates optimization of treatments for GIST.
Abkürzungen
GISTs
Gastrointestinal stromal tumors
HCV
Hepatitis C virus
HIV
Human immunodeficiency virus

Background

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the digestive tract. Although GISTs only occur in less than 5% of all gastrointestinal tract tumors, they account for 60% of all gastric stromal tumors [1]. GISTs are typically solid tumors and rarely present with predominantly cystic changes [2]. Here, we describe a case of giant GIST of the stomach with predominantly cystic changes that was cured with complete surgical resection without regional lymphadenectomy.

Case presentation

A 74-year-old female patient was hospitalized because of worsening abdominal pain for 2 days. The patient had distending upper abdominal pain for 3 months. The pain was intermittent and dull and did not radiate. She had no nausea or vomiting. Two days before admission, the pain worsened without apparent causes. The patient had no fever, and urine and stool were normal. She had no respiratory symptoms except occasional cough and whitish sputum. The patient had a history of hypertension for 5 years; the blood pressure was as high as 190/90 mmHg, and the patient took oral nifedipine (30 mg/day, sustained release tablet, Bayer).
Physical examination at admission showed tenderness in the mid and upper left abdomen, but no rebound tenderness was elicited. A mass was palpated in the upper left abdomen. The mass was approximately 10 cm in diameter and had an indistinct boundary and was poorly mobile. The findings were otherwise unremarkable. Laboratory findings including blood chemistries, routine blood tests, coagulation profile, and tumor markers were normal. Immunological tests for antigens or antibodies related to infections with Treponema pallidum, HIV (human immunodeficiency virus), and HCV (hepatitis C virus) were negative. Abdominal ultrasonography revealed a hypoechoic intraperitoneal mass in the upper left quadrant, 13.3 cm × 12.5 cm in size, with punctate hyperechoic deposits. The wall of the cyst was rough, with many irregular hyperechoic protuberances. Abdominal CT showed a cystic hypointense shadow with septations, approximately 15.6 cm × 14.7 cm × 13.6 cm in size (Fig. 1). The stomach was compressed by the tumor and was not clearly visualized. The pancreatic gland was displaced anteriorly by the tumor, and the border between the tail of the pancreas and the tumor was indistinct. The spleen and the left kidney were displaced inferiorly by the tumor. Gastric endoscopy revealed protuberances in the fundus, suggestive of external compression.
Exploratory laparotomy showed a cystic mass in the left upper quadrant, 10 cm × 15 cm in size, starting from the posterior wall of the gastric fundus and had intimate relations with the spleen and the greater curvature of the gastric fundus. Rapid pathological examination indicated gastric stromal tumors. The tumor, the proximal stomach, and the spleen were excised. The tumor had a maximal diameter of 15 cm, with necrosis and cystic degeneration (Fig. 2). No invasion of the spleen was seen. No intraperitoneal lymph node metastasis (0/3) and no metastasis to peritumoral lymph nodes (0/6) were observed. Distant metastases, such as in the liver and lung, were also not observed. Postoperative pathological examination showed GIST (high grade, spindle cell variant). The mitotic index was 10/50 in high-power field. Immunohistochemical study revealed CD117 (+), H-caldesmon (+), SMA (weak +), DOG-1 (+), CD34 (−), desmin (−), Ki67 (5% positive), NSE (−), and S-100 (−). No peritoneal metastasis was present. The patient recovered uneventfully and discharged from hospital after 2 weeks. The patient received regular follow-up, and no recurrence has occurred at the time of writing this case report (20 months following surgery).

Discussion and conclusions

GISTs are the most common mesenchymal tumors and account for 0.1 to 3% of all gastrointestinal tumors [1]. GISTs had been considered to be smooth muscle neoplasms such as leiomyoma or leiomyosarcoma; subsequent studies have demonstrated that GIST arises from c-KIT (CD117)-positive intestinal cells of Cajal in the gastrointestinal tract. The clinical manifestations of GIST are non-specific and vary from being asymptomatic to abdominal pain, a palpable mass, bleeding, intestinal occlusion, and perforation. The diagnosis of GIST of the stomach is frequently not clear preoperatively, as in the current case. GISTs of the stomach with cystic changes are not common and may be misdiagnosed as hepatic or pancreatic lesions [3, 4]. The tumor in our case had intimate relations with adjacent structures such as the liver and spleen and its border was indistinct from the pancreatic tail. Though abdominal ultrasonography, CT scan, and gastric endoscopy were performed in our patient, these diagnostic modalities failed to yield a definite diagnosis. Histologically, the tumor is composed of interlacing bundles or whorls of spindle-shaped cells. However, histological findings are noncommittal and definite diagnosis relies on immunohistochemical studies. CD117 is positive in 90% of the cases of GIST. The tumor tissue specimen in the current case was also intensely positive for CD117. Our patient was also positive for DOG1, another sensitive marker that is positive in 95% of the cases [4], but negative for CD34, which is positive in 50 to 80% of the cases [4].
One noticeable feature of our case is the presence of predominantly cystic changes in the tumor. GISTs often form solid tumors and are rarely predominantly cystic. GISTs with cystic changes are more frequently seen in high-grade malignancies. Because of aggressive tumor growth, necrosis, hemorrhage, liquefaction, and cystic degeneration occur from lack of adequate blood supply, leading to formation of large cystic spaces [5]. Necrosis and cystic degeneration were also seen in the tumor of our patient. GISTs are typically large tumors, with diameters greater than 10 cm. Okano et al. reviewed six reported cases of GIST with cystic changes, and the size of these tumors varied from 6 to 32 cm [2]. We further reviewed the English and Chinese literature and summarize the reported cases in Table 1 [4, 613]. These patients had a median age of 66 years (range 11 to 80 years) and five of them (45.5%, 5/11) were female. The cyst size ranged from 6 to 37.6 cm.
Table 1
Clinical features of reported cases of GISTs of the stomach with cystic formation in the literature
Case no.
Reference
Age, years
Gender
Size, cm
Location
Rupture or perforation
Mitotic figures
Surgery
Imatinib
Follow-up duration, months
Recurrence
1
Park et al.
11
F
10
The anterior gastric wall
No
Yes
Yes
9
No
2
Osada et al.
74
M
12
The gastric wall in the posterior aspect of the fundus
Yes
High mitotic count
Yes
Yes
24
No
3
Cruz Jr. et al.
37
M
32
The distal part of stomach
No
10/50 HPF
Yes
Yes
12
No
4
Yu et al.
80
F
6
The front of the stomach
Yes
4/50 HPF
Yes
5
Notani et al.
58
M
33
The gastric wall
No
Yes
Yes
12
No
6
Zhu et al.
78
M
17
The gastric wall
No
> 10/50 HPF
Yes
No
36
No
7
Okano et al.
79
M
60
The gastric wall
No
> 5/50 HPF
Yes
No
12
No
8
Colović et al.
52
F
 
The greater curvature of the stomach
No
Yes
Yes
24
No
9
Chen XQ et al.
60
M
28.5
The posterior wall of the gastric body
No
Yes
No
12
No
10
Yang CB
66
F
37.6
The posterior wall of the gastric body
No
Yes
11
The current case
74
F
15
The gastric wall in the posterior aspect of the fundus
No
> 10/50 HPF
Yes
No
20
No
GISTs possess malignant potential and are highly invasive and tend to metastasize to remote organs [8]. Metastases of GIST commonly develop in the abdominal cavity and liver, and rarely in the lymph nodes. Though necrosis and cystic degeneration were observed in the tumor specimen of our patient, we observed no metastasis to lymph nodes and remote organs. The tumor was completely encapsulated, and invasion to adjacent tissues was not seen. This may explain that no tumor recurrence has occurred following complete surgical resection of the tumor. Wang et al. reported seven cases of GIST with cystic changes and found no recurrence 9 to 80 months following surgical resection [14].
GISTs of the stomach with cystic changes are rare and may defy diagnosis preoperatively. Our case illustrates that GIST with cystic changes should be considered in the diagnoses of hepatic and pancreatic lesions. Furthermore, immunohistochemistry with CD117, DOG1, and other molecular markers is critical for diagnosis of GIST of the stomach and facilitates optimization of treatments for GIST.

Funding

No funding was received for this study.

Availability of data and materials

All data and materials on which the conclusions of the paper rely be presented in the main paper.
Not applicable.
Informed consent for publication was obtained from the patient.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.PubMed Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.PubMed
2.
Zurück zum Zitat Okano H, Tochio T, Suga D, Kumazawa H, Isono Y, Tanaka H, et al. A case of a stomach gastrointestinal stromal tumor with extremely predominant cystic formation. Clin J Gastroenterol. 2015;8:197–201.CrossRefPubMed Okano H, Tochio T, Suga D, Kumazawa H, Isono Y, Tanaka H, et al. A case of a stomach gastrointestinal stromal tumor with extremely predominant cystic formation. Clin J Gastroenterol. 2015;8:197–201.CrossRefPubMed
3.
Zurück zum Zitat Hansen Cde A, Jose FF, Caluz NP. Gastrointestinal stromal tumor (GIST) mistaken for pancreatic pseudocyst—case report and literature review. Clin Case Rep. 2014;2:197–200.CrossRefPubMed Hansen Cde A, Jose FF, Caluz NP. Gastrointestinal stromal tumor (GIST) mistaken for pancreatic pseudocyst—case report and literature review. Clin Case Rep. 2014;2:197–200.CrossRefPubMed
4.
Zurück zum Zitat Zhu CC, Liu Y, Zhao G. Exophytic gastrointestinal stromal tumor with cystic changes: a case report. Oncol Lett. 2014;7:1427–9.PubMedPubMedCentral Zhu CC, Liu Y, Zhao G. Exophytic gastrointestinal stromal tumor with cystic changes: a case report. Oncol Lett. 2014;7:1427–9.PubMedPubMedCentral
5.
Zurück zum Zitat Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 2003;23:283-304, 456; quiz 532. Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 2003;23:283-304, 456; quiz 532.
6.
Zurück zum Zitat Osada T, Nagahara A, Kodani T, Namihisa A, Kawabe M, Yoshizawa T, et al. Gastrointestinal stromal tumor of the stomach with a giant abscess penetrating the gastric lumen. World J Gastroenterol. 2007;13:2385–7.CrossRefPubMedPubMedCentral Osada T, Nagahara A, Kodani T, Namihisa A, Kawabe M, Yoshizawa T, et al. Gastrointestinal stromal tumor of the stomach with a giant abscess penetrating the gastric lumen. World J Gastroenterol. 2007;13:2385–7.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Park J, Rubinas TC, Fordham LA, Phillips JD. Multifocal gastrointestinal stromal tumor (GIST) of the stomach in an 11-year-old girl. Pediatr Radiol. 2006;36:1212–4.CrossRefPubMed Park J, Rubinas TC, Fordham LA, Phillips JD. Multifocal gastrointestinal stromal tumor (GIST) of the stomach in an 11-year-old girl. Pediatr Radiol. 2006;36:1212–4.CrossRefPubMed
8.
Zurück zum Zitat Colovic R, Micev M, Matic S, Colovic N, Grubor N. Atkinson HD malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate. Vojnosanit Pregl. 2013;70:225–8.CrossRefPubMed Colovic R, Micev M, Matic S, Colovic N, Grubor N. Atkinson HD malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate. Vojnosanit Pregl. 2013;70:225–8.CrossRefPubMed
9.
Zurück zum Zitat Cruz RJ Jr, Vincenzi R, Ketzer BM, Cecilio AL. Cepeda LA spontaneous intratumoral bleeding and rupture of giant gastric stromal tumor (>30 cm) in a young patient. World J Surg Oncol. 2008;6:76.CrossRefPubMedPubMedCentral Cruz RJ Jr, Vincenzi R, Ketzer BM, Cecilio AL. Cepeda LA spontaneous intratumoral bleeding and rupture of giant gastric stromal tumor (>30 cm) in a young patient. World J Surg Oncol. 2008;6:76.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Notani H, Kawamura T, Sato T, Hoshino A, Sato Y, Nakajima A. A case of a giant gastrointestinal stromal tumor of the stomach with extramural growth. Gan To Kagaku Ryoho. 2013;40:2179–81.PubMed Notani H, Kawamura T, Sato T, Hoshino A, Sato Y, Nakajima A. A case of a giant gastrointestinal stromal tumor of the stomach with extramural growth. Gan To Kagaku Ryoho. 2013;40:2179–81.PubMed
11.
Zurück zum Zitat Yu CC, Wu CC, Hwang JI, Wang J, Chang CS. Thick calcification from a GIST of the stomach penetrating into pericolic soft tissue—report of a case. World J Surg Oncol. 2011;9:45.CrossRefPubMedPubMedCentral Yu CC, Wu CC, Hwang JI, Wang J, Chang CS. Thick calcification from a GIST of the stomach penetrating into pericolic soft tissue—report of a case. World J Surg Oncol. 2011;9:45.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Chen XQ, Lv HZ, Ye XY, Zhang WH, Zhang F, Zhang S. Diagnosis and treatment of huge gastrointestinal stromal tumor combined with large inguinal hernia. Chinese Journal of Digestive Surgery. 2013;12:475–6. Chen XQ, Lv HZ, Ye XY, Zhang WH, Zhang F, Zhang S. Diagnosis and treatment of huge gastrointestinal stromal tumor combined with large inguinal hernia. Chinese Journal of Digestive Surgery. 2013;12:475–6.
13.
Zurück zum Zitat Yang CB, Jia YY, Yu Y, He TP, Duan HF, Zhang XR, et al. Giant cystic gastric stromal tumor with large external cavity growth: case report. Chinese Journal of Medical Imaging Technology. 2015;31:1448–9. Yang CB, Jia YY, Yu Y, He TP, Duan HF, Zhang XR, et al. Giant cystic gastric stromal tumor with large external cavity growth: case report. Chinese Journal of Medical Imaging Technology. 2015;31:1448–9.
14.
Zurück zum Zitat Wang CZ, Hou YY, Shen KT, Wang HS, Qin J, Sun YH, et al. Clinicopathological features and prognosis of cystic gastrointestinal stromal tumor. Zhonghua Wei Chang Wai Ke Za Zhi. 2011;14:599–602.PubMed Wang CZ, Hou YY, Shen KT, Wang HS, Qin J, Sun YH, et al. Clinicopathological features and prognosis of cystic gastrointestinal stromal tumor. Zhonghua Wei Chang Wai Ke Za Zhi. 2011;14:599–602.PubMed
Metadaten
Titel
Giant gastrointestinal stromal tumor with predominantly cystic changes: a case report and literature review
verfasst von
Liying Wang
Libin Liu
Zhaohui Liu
Yueli Tian
Zhe Lin
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2017
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-017-1285-2

Weitere Artikel der Ausgabe 1/2017

World Journal of Surgical Oncology 1/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.